Janney Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.23M | Sell |
16,231
-276
| -2% | -$123K | 0.47% | 88 |
|
|
2025
Q1 | $8M | Sell |
16,507
-82
| -0.5% | -$39.8K | 0.55% | 84 |
|
|
2024
Q4 | $6.68M | Sell |
16,589
-566
| -3% | -$228K | 0.44% | 86 |
|
|
2024
Q3 | $7.98M | Sell |
17,155
-183
| -1% | -$85.1K | 0.54% | 83 |
|
|
2024
Q2 | $8.13M | Sell |
17,338
-69
| -0.4% | -$32.3K | 0.57% | 72 |
|
|
2024
Q1 | $7.28M | Sell |
17,407
-491
| -3% | -$205K | 0.48% | 85 |
|
|
2023
Q4 | $7.28M | Sell |
17,898
-192
| -1% | -$78.1K | 0.49% | 82 |
|
|
2023
Q3 | $6.29M | Sell |
18,090
-113
| -0.6% | -$39.3K | 0.48% | 75 |
|
|
2023
Q2 | $6.41M | Sell |
18,203
-216
| -1% | -$76K | 0.44% | 82 |
|
|
2023
Q1 | $5.8M | Buy |
18,419
+598
| +3% | +$188K | 0.44% | 80 |
|
|
2022
Q4 | $5.15M | Buy |
+17,821
| New | +$5.15M | 0.37% | 89 |
|